NERLYNX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 20 Feb 2024)
What this means for you
Registered since 17 Oct 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 17 Oct 2027, and its filing window is open now).
Record
- Serial number
- 86678985
- Registration number
- 5311871
- Mark type
- Word mark
- Filed
- 30 Jun 2015
- Published for opposition
- 17 Nov 2015
- Registered
- 17 Oct 2017
- Next maintenance filing
- §8 & §9 renewal, due by 17 Oct 2027 (grace period to 17 Apr 2028)
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer
Owner
- Puma Biotechnology Inc., Los Angeles, CA, US
- Puma Biotechnology Inc., Los Angeles, CA, US
- Puma Biotechnology Inc., Los Angeles, CA, US
Prosecution history
- 17 Oct 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Sept 2023 — TEAS SECTION 8 & 15 RECEIVED
- 17 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Aug 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 17 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 12 Sept 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Sept 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Aug 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2017 — USE AMENDMENT FILED
- 18 Aug 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jul 2017 — TEAS STATEMENT OF USE RECEIVED
- 12 Jul 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED